177 related articles for article (PubMed ID: 34310015)
1. Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study.
O'Bryant S; Petersen M; Hall J; Johnson L; Yaffe K; Braskie M; Toga AW; Rissman RA;
Alzheimers Dement; 2022 Feb; 18(2):240-250. PubMed ID: 34310015
[TBL] [Abstract][Full Text] [Related]
2. A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research.
O'Bryant SE; Zhang F; Petersen M; Hall JR; Johnson LA; Yaffe K; Mason D; Braskie M; Barber RA; Rissman RA; Mapstone M; Mielke MM; Toga AW;
Alzheimers Dement; 2022 Jan; 18(1):77-87. PubMed ID: 34057802
[TBL] [Abstract][Full Text] [Related]
3. Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia.
Hall JR; Johnson LA; Peterson M; Julovich D; Como T; O'Bryant SE
Curr Alzheimer Res; 2020; 17(13):1214-1220. PubMed ID: 33605860
[TBL] [Abstract][Full Text] [Related]
4. Using Fractional Anisotropy Imaging to Detect Mild Cognitive Impairment and Alzheimer's Disease among Mexican Americans and Non-Hispanic Whites: A HABLE Study.
Hall JR; Johnson LA; Zhang F; Petersen M; Toga AW; Shi Y; Mason D; Rissman RA; Yaffe K; O'Bryant SE;
Dement Geriatr Cogn Disord; 2021; 50(3):266-273. PubMed ID: 34569492
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.
O'Bryant SE; Zhang F; Petersen M; Hall JR; Johnson LA; Yaffe K; Braskie M; Vig R; Toga AW; Rissman RA;
J Alzheimers Dis; 2022; 86(3):1243-1254. PubMed ID: 35180110
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
7. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
8. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
[TBL] [Abstract][Full Text] [Related]
9. The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD).
Yu F; Pituch KA; Maxfield M; Baena E; Geda YE; Pruzin JJ; Coon DW; Shaibi GQ;
PLoS One; 2024; 19(4):e0295749. PubMed ID: 38558059
[TBL] [Abstract][Full Text] [Related]
10. Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non-Hispanic Whites: A Health & Aging Brain among Latino Elders (HABLE) Study.
O'Bryant SE; Zhang F; Petersen M; Hall J; Johnson LA; Yaffe K; Braskie M; Rissman RA; Vig R; Toga AW;
Alzheimers Dement (Amst); 2022; 14(1):e12267. PubMed ID: 35155729
[TBL] [Abstract][Full Text] [Related]
11. Serum neurofilament light chain level as a predictor of cognitive stage transition.
Lee EH; Kwon HS; Koh SH; Choi SH; Jin JH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J
Alzheimers Res Ther; 2022 Jan; 14(1):6. PubMed ID: 34996525
[TBL] [Abstract][Full Text] [Related]
12. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
13. Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease.
Pagonabarraga J; Pérez-González R; Bejr-Kasem H; Marín-Lahoz J; Horta-Barba A; Martinez-Horta S; Aracil-Bolaños I; Sampedro F; Campolongo A; Rivas E; Puig-Davi A; Ruiz-Barrios I; Pérez-Pérez J; Pascual-Sedano B; Kulisevsky J
Parkinsonism Relat Disord; 2022 Dec; 105():132-138. PubMed ID: 35752549
[TBL] [Abstract][Full Text] [Related]
14. Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
Giacomucci G; Mazzeo S; Bagnoli S; Ingannato A; Leccese D; Berti V; Padiglioni S; Galdo G; Ferrari C; Sorbi S; Bessi V; Nacmias B
J Neurol; 2022 Aug; 269(8):4270-4280. PubMed ID: 35288777
[TBL] [Abstract][Full Text] [Related]
15. Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment.
Asken BM; VandeVrede L; Rojas JC; Fonseca C; Staffaroni AM; Elahi FM; Lindbergh CA; Apple AC; You M; Weiner-Light S; Brathaban N; Fernandes N; Boxer AL; Miller BL; Rosen HJ; Kramer JH; Casaletto KB
J Int Neuropsychol Soc; 2022 Jul; 28(6):588-599. PubMed ID: 34158138
[TBL] [Abstract][Full Text] [Related]
16. Characterizing Plasma Biomarkers of Alzheimer's in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort.
Hall JR; Petersen M; Johnson L; O'Bryant SE
Front Neurol; 2022; 13():871947. PubMed ID: 36062019
[TBL] [Abstract][Full Text] [Related]
17. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
Chouliaras L; Thomas A; Malpetti M; Donaghy P; Kane J; Mak E; Savulich G; Prats-Sedano MA; Heslegrave AJ; Zetterberg H; Su L; Rowe JB; O'Brien JT
J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):651-658. PubMed ID: 35078917
[TBL] [Abstract][Full Text] [Related]
18. Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain.
Chen CY; Chiu CC; Huang CY; Cheng YC; Huang MC; Kuo PH; Chen WY
BMC Geriatr; 2024 Apr; 24(1):344. PubMed ID: 38627748
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.
O'Bryant SE; Petersen M; Hall J; Johnson LA; Barber R; Phillips N; Braskie MN; Yaffe K; Rissman R; Toga A;
J Alzheimers Dis; 2022; 90(2):905-915. PubMed ID: 36189588
[TBL] [Abstract][Full Text] [Related]
20. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.
Huang Y; Li Y; Xie F; Guo Q
CNS Neurosci Ther; 2022 Dec; 28(12):2195-2205. PubMed ID: 36074638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
